Matthew Harms

Matthew Harms has extensive experience in the biopharmaceutical industry, showcasing a strong background in commercial strategy, business insights, and analytics. Their roles at Umoja Biopharma, Juno Therapeutics, Inc., and Baxalta involved leadership in various commercial projects, strategic assessments, and corporate operations support. With a solid foundation in consulting and finance, Matthew's career progression highlights their adaptability and expertise in driving business growth and development. Their academic background includes an MBA from the University of Michigan and a B.Sc. in Economics from Truman State University.